^○Daisuke Kodama¹, Masakazu Tanaka¹, Kimiko Izumo¹, Toshio Matsuzaki², Eiji Matsuura³, Hiroshi Takashima³, Shuji Izumo¹, Ryuji Kubota¹ (1.Kagoshima University, Joint Research Center for Human Retrovirus Infection, Division of Neuroimmunology, Japan, 2.Medical Corporation Sanshukai, Ohkatsu Hospital, Department of Neurology, 3.Kagoshima University Graduate School of Medical and Dental Sciences, Department of Neurology and Geriatrics)

^○Toshiaki Hirai¹, Yoshiyuki Kuroiwa¹, Yasuhisa Baba¹, Hidetoshi Tahara² (1.Departments of Neurology and Stroke Center, Mizonokuchi Hospital, Teikyo University School of Medicine,, Japan, 2.Department of Cellular and Molecular Biology, Graduate School of Biomedical Sciences, Hiroshima University)

^○Satoshi Nozuma^1,3, Eiji Matsuura¹, Toshio Matsuzaki², Ryuji Kubota², Steven Jacobson³, Hiroshi Takashima¹ (1.Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan, 2.Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 3.Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorder and Stroke, National Institutes of Health)

^○Toshihiko Maeda, Masatoshi Omoto (Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan)

^○Keiko Maruyama Saladini (Novartis Pharma K.K. Global Drug Development, Japan)

^○Jin Nakahara¹, Takahiko Saida², Denis V. Sazanov³, Takayoshi Kurosawa⁴, Isao Tsumiyama⁴, Roman Willi⁵, Martin Zalesak⁵, Ratnakar Pingili⁶, Dieter A. Häring⁵, Krishnan Ramanathan⁵, Jun-ichi Kira⁷ (1.Department of Neurology, Keio University School of Medicine, Japan, 2.Kansai Multiple Sclerosis Center and Kyoto Min-iren Central Hospital, 3.Siberian District Medical Centre of the Federal Medical and Biological Agency of Russia, 4.Novartis Pharma KK, 5.Novartis Pharma AG, 6.Novartis Pharmaceuticals Corporation, 7.Translational Neuroscience Center, Graduate School of Medicine, International University of Health and Welfare and Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital)

^○Takuya Matsushita¹, Eizo Tanaka¹, Noriko Isobe¹, Mitsuru Watanabe¹, Shoko Fukumoto¹, Fumie Hayashi¹, Ken Yamamoto², Ryo Yamasaki¹, Jun-ichi Kira^1,3,4 (1.Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Medical Chemistry, School of Medicine, Kurume University, 3.2Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, 4.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare)

^○Atsuko Katsumoto¹, Youwei Lin¹, Wakiro Sato², Tomoko Okamoto¹, Takashi Yamamura², Yuji Takahashi¹ (1.Department of Neurology, National Center Hospital of Neurology and Psychiatry, Japan, 2.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

^○Kengo Ueda (Neuroscience Medical Franchise Dept. Medical Division, Novartis Pharma K.K., Japan)